Bringing back transparency in drug regulations at Health Canada

Physicians, researchers and other members of the biomedical community in Canada should demand information on drug safety and effectiveness, argues Matthew Herder, law professor at Dalhousie University in Halifax, Nova Scotia.

"Write to the Minister of Health to request drug safety and effectiveness data from Health Canada; push the regulator for better terms of access to enable meaningful, independent scrutiny of pharmaceutical data and help motivate institutional change," he states in a Humanities article in CMAJ (Canadian Medical Association Journal).

###